Loading...

Buy Full Version
"Vital Organs Support Systems and Medical Bionics Market"

Let us help you !

Invalid Email.

Please Select Country.

Invalid contact no.

Special Symbols Not Allowed.

Invalid Security Code.

Thank You For Your Interest.

We've Successfully Got Your Message,

Our Executive will get back to you Shortly.

Vital Organs Support Systems and Medical Bionics Market by Product (Vital organs support systems and Medical Bionics) and End User (Hospitals, Ambulatory Surgical Centers, and Others): Global Opportunity Analysis and Industry Forecast, 2018–2025

LI_195283
Pages: 293
May 2019 | 1344 Views
 
Author(s) : Surabhi Pandey , Onkar Sumant
Tables: 101
Charts: 69
 

Vital Organs Support Systems and Medical Bionics Market Outlook - 2025

The global vital organs support systems and medical bionics market size in 2017 was $28,169 million, and is projected to reach $59,412 million by 2025, growing at a CAGR of 9.9% from 2018 to 2025.

Artificial organ is a device designed to replace the functions of missing or faulty organ, thereby restoring the functions of original organ. Medical bionics refers to the study of artificial body parts that are substituted for a natural biological capability. Organ transplantation has evolved as a common practice, which has fueled the development of the healthcare industry. High demand has been witnessed from patients for organ transplantation surgery, whereas availability of the donors to meet this demand is low. This has resulted in a wider supply–demand gap, which in turn has aided in increasing the global vital organs support systems and medical bionics market share. 

Vital Organs Support Systems and Medical Bionics Market

Get more information on this report : Request Sample Pages
 

The growth of the global market is driven by rise in incidence of cardiac disorders and upsurge in geriatric population. In addition, rise in number of patients suffering from chronic diseases and technological advancements in medical devices drive the vital organs support systems and medical bionics market growth. However, high cost of treatment and stringent approval process are projected to impede the growth of the market. On the contrary, lucrative opportunities in emerging economies are expected to provide significant prospects for the manufacturers in the industry.

Vital Organs Support Systems and Medical Bionics Market By Type

Get more information on this report : Request Sample Pages

Product segment review

Based on product, the vital organs support systems and medical bionics market is categorized into vital organs support systems and medical bionics. The vital organs support systems market is further classified into artificial heart, artificial kidney, artificial pancreas, artificial urinary bladder, artificial lungs, and artificial liver. The medical bionics market is subsegmented into bionic eye, ear bionics, orthopedic bionics, cardiac bionics, and neural bionics. The medical bionics segment was the major revenue contributor in 2017, and is anticipated to continue this trend during the forecast period, owing to rise in geriatric population, upsurge in number of patients suffering from chronic diseases, and increase in government focus on funding R&D initiatives.

Vital Organs Support Systems and Medical Bionics Market By End Use

Get more information on this report : Request Sample Pages

End user segment review

Depending on end user, the vital organs support systems and medical bionics market is fragmented into hospitals, ambulatory surgical centers, and others. The ambulatory surgical centers segment is projected to exhibit the highest growth during the forecast period. This is attributed to surge in demand for high-quality, cost-effective alternative to inpatient hospital care for surgical services. However, the hospitals segment was the major revenue contributor in 2017, and is anticipated to continue this trend during the forecast period, owing to the availability of various support departments such as MRI suites and ICUs as compared to ASCs. In addition, hospitals have more resources to manage complications, and patients are often transferred from an ambulatory surgery center to the nearest hospital when complications arise during a procedure.

Vital Organs Support Systems and Medical Bionics Market By Region

Get more information on this report : Request Sample Pages

Region segment review

Region wise, the vital organs support systems and medical bionics market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. Asia-Pacific is projected to exhibit the highest growth during the vital organs support systems and medical bionics market forecast period, owing to government & private sector initiatives to increase awareness regarding artificial organs transplantation, increase in R&D expenditure, and increase in incidence of chronic disorders.

The report provides a comprehensive vital organs support systems and medical bionics market analysis of the key players operating in the global market, namely, Abiomed, Inc., Abbott Laboratories, Asahi Kasei Corporation (Evaheart Medical U.S.A., Inc.), Baxter International Inc., Boston Scientific Corporation, Cochlear Ltd., Edwards Lifesciences Corporation, Jarvik Heart, Inc., Medtronic Plc., Össur Americas, Inc., Second Sight Medical Products, Inc., and SynCardia Systems LLC. The other players in the value chain include Getinge AB, LivaNova PLC, Fresenius Medical Care AG & Co. KGaA, Heartware International Inc., BiVACOR, and others.

Key Benefits for Vital Organs Support Systems and Medical Bionics Market:

  • This report provides a detailed quantitative analysis of the current vital organs support systems and medical bionics market trends and estimations from 2018 to 2025, which assists to identify the prevailing vital organs support systems and medical bionics market opportunities. 
  • An in-depth vital organs support systems and medical bionics market analysis of various regions is anticipated to provide a detailed understanding of the current trends to enable stakeholders formulate region-specific plans.
  • A comprehensive analysis of the factors that drive and restrain the growth of the global vital organs support systems and medical bionics market is provided.
  • Region-wise and country-wise vital organs support systems and medical bionics market conditions are comprehensively analyzed in this report.
  • The projections in this report are made by analyzing the current trends and future market potential from 2018 to 2025 in terms of value.
  • An extensive analysis of various regions provides insights that are expected to allow companies to strategically plan their business moves.
  • Key market players within the vital organs support systems and medical bionics market are profiled in this report and their strategies are analyzed thoroughly, which helps to understand the competitive outlook of the global market.

Vital Organs Support Systems and Medical Bionics Market Key Segments:

By Product 

  • Vital organs support systems
    • Artificial Heart
    • Artificial Kidney
    • Artificial Pancreas
    • Artificial Urinary Bladder
    • Artificial Lungs
    • Artificial Liver
  • Medical Bionics
    • Bionic Eye
    • Ear Bionics
      • Cochlear Implants
      • Bone Anchored Hearing Systems
      • Auditory Brainstem Implants
    • Orthopedic Bionics
      • Upper Limb
      • Lower Limb
        • Bionic Knee
        • Bionic Feet
      • Exoskeleton
      • Electrical Bone Growth Stimulators
        • Noninvasive Bone Growth Stimulators
        • Invasive Bone Growth Stimulators
    • Cardiac Bionics
      • Pacemaker
        • Implantable pacemaker
        • External pacemaker
      • Ventricular Assist Device
        • Left Ventricular Assist Device (LVAD)
        • Right Ventricular Assist Device (RVAD)
        • Biventricular Assist Device (BIVAD)
      • Artificial Heart Valves
        • Mechanical Heart Valves
        • Tissue Heart Valves
    • Neural Bionics
      • Internal Neurostimulators
        • Deep Brain Stimulators (DBS)
        • Sacral Nerve Stimulators (SNS)
        • Vagus Nerve Stimulators (VNS)
        • Spinal Cord Stimulators (SCS)
        • Other Neurostimulators
    • External Neurostimulators (Transcutaneous Electrical Nerve Stimulation (TENS))

By End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • Australia
    • Japan
    • India
    • China
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA
 

CHAPTER 1:    INTRODUCTION

1.1.    Report description
1.2.    Key benefits for stakeholders
1.3.    Key market segments
1.4.    Research methodology

1.4.1.    Primary research
1.4.2.    Secondary research
1.4.3.    Analyst tools and models

CHAPTER 2:    EXECUTIVE SUMMARY

2.1.    CXO perspective
2.2.    Key findings

2.2.1.    Top impacting factors
2.2.2.    Top investment pockets

CHAPTER 3:    MARKET OVERVIEW

3.1.    Market definition and scope
3.2.    Key Forces Shaping vital organs support systems and medical bionics Market

3.2.1.    High bargaining power of suppliers
3.2.2.    Low threat of new entrants
3.2.3.    High threat of substitutes
3.2.4.    High intensity of rivalry
3.2.5.    Moderate bargaining power of buyers

3.4.    Pricing Analysis

3.4.1.    Pricing Analysis of Vital Organs Support Systems, By Region, 2018 & 2025
3.4.2.    Pricing Analysis of Medical Bionics, By Region, 2018 & 2025

3.5.    Value Chain Analysis
3.6.    Impact of government regulations on global vital organs support systems and medical bionics market
3.7.    Clinical Trials
3.8.    Industry Pain point analysis
3.9.    Case Studies

3.9.1.    Case Study 01

3.10.    Market dynamics

3.10.1.    Drivers

3.10.1.1.    Increase in incidence of cardiac disorders and growth in geriatric population
3.10.1.2.    Rise in number of patients suffering from chronic diseases
3.10.1.3.    Technological advancements

3.10.2.    Restraints

3.10.2.1.    High cost of treatment
3.10.2.2.    Stringent approval process

3.10.3.    Opportunity

3.10.3.1.    Lucrative opportunities in emerging economies

CHAPTER 4:    VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE

4.1.    Overview
4.2.    Market size and forecast

4.3.    Vital organs support systems

4.3.1.    Key market trends, growth factors and opportunities
4.3.2.    Market size and forecast, by type

4.3.2.1.    Artificial Heart

4.3.2.1.1.    Market size and forecast

4.3.2.2.    Artificial Kidney

4.3.2.2.1.    Market size and forecast

4.3.2.3.    Artificial Pancreas

4.3.2.3.1.    Market size and forecast

4.3.2.4.    Artificial Urinary Bladder

4.3.2.4.1.    Market size and forecast

4.3.2.5.    Artificial Lungs

4.3.2.5.1.    Market size and forecast

4.3.2.6.    Artificial Liver

4.3.2.6.1.    Market size and forecast

4.3.3.    Market size and forecast, by region
4.3.4.    Market analysis by country

4.4.    Medical Bionics

4.4.1.    Key market trends, growth factors and opportunities
4.4.2.    Market size and forecast, by type

4.4.2.1.    Bionic Eye

4.4.2.1.1.    Market size and forecast

4.4.2.2.    Ear Bionics

4.4.2.2.1.    Market size and forecast, by type

4.4.2.2.1.1.Cochlear Implants

4.4.2.2.1.1.1. Market size and forecast

4.4.2.2.1.2.Bone Anchored Hearing Systems

4.4.2.2.1.2.1. Market size and forecast

4.4.2.2.1.3.Auditory Brainstem Implants

4.4.2.2.1.3.1. Market size and forecast

4.4.2.3.    Orthopedic Bionics

4.4.2.3.1.    Market size and forecast, by type

4.4.2.3.1.1.Upper Limb

4.4.2.3.1.1.1. Market size and forecast

4.4.2.3.1.2.Lower Limb

4.4.2.3.1.2.1. Market size and forecast, by type

4.4.2.3.1.2.1.1. Bionic Knee

4.4.2.3.1.2.1.1.1.    Market size and forecast

4.4.2.3.1.2.1.2. Bionic Feet

4.4.2.3.1.2.1.2.1.    Market size and forecast

4.4.2.3.1.3.   Exoskeleton

4.4.2.3.1.3.1. Market size and forecast

4.4.2.3.1.4.    Electrical Bone Growth Stimulators

4.4.2.3.1.4.1. Market size and forecast, by type

4.4.2.3.1.4.1.1.    Invasive Bone Growth Stimulators

4.4.2.3.1.4.1.1.1. Market size and forecast

4.4.2.3.1.4.1.2.Non-Invasive Bone Growth Stimulators

4.4.2.3.1.4.1.2.1.Market size and forecast

4.4.2.4.    Cardiac Bionics

4.4.2.4.1.    Market size and forecast, by type

4.4.2.4.1.1.Pacemaker

4.4.2.4.1.1.1.Market size and forecast, by type

4.4.2.4.1.1.1.1.Implantable Pacemaker

4.4.2.4.1.1.1.1.1.    Market size and forecast

4.4.2.4.1.1.1.2.External pacemaker

4.4.2.4.1.1.1.2.1.    Market size and forecast

4.4.2.4.1.2.Ventricular Assist Devices (VADs)

4.4.2.4.1.2.1.Market size and forecast, by type

4.4.2.4.1.2.1.1.    Left Ventricular Assist Device (LVAD)

4.4.2.4.1.2.1.1.1.    Market size and forecast

4.4.2.4.1.2.1.2.Right Ventricular Assist Device (RVAD)

4.4.2.4.1.2.1.2.1.    Market size and forecast

4.4.2.4.1.2.1.3.    Biventricular Assist Device (BIVAD)

4.4.2.4.1.2.1.3.1.    Market size and forecast

4.4.2.4.1.3.    Artificial Heart Valves

4.4.2.4.1.3.1.Market size and forecast, by type

4.4.2.4.1.3.1.1.Mechanical Heart Valves

4.4.2.4.1.3.1.1.1.Market size and forecast

4.4.2.4.1.3.1.2.Tissue Heart Valves

4.4.2.4.1.3.1.2.1.    Market size and forecast

4.4.2.5.    Neural Bionics

4.4.2.5.1.    Market size and forecast, by type

4.4.2.5.1.1. Internal Neurostimulators

4.4.2.5.1.1.1.Market size and forecast, by type

4.4.2.5.1.1.1.1.Deep Brain Stimulators (DBS)

4.4.2.5.1.1.1.1.1.Market size and forecast

4.4.2.5.1.1.1.2.Sacral Nerve Stimulators (SNS)

4.4.2.5.1.1.1.2.1.    Market size and forecast

4.4.2.5.1.1.1.3.Vagus Nerve Stimulators (VNS)

4.4.2.5.1.1.1.3.1.    Market size and forecast

4.4.2.5.1.1.1.4.Spinal Cord Stimulators (SCS)

4.4.2.5.1.1.1.4.1.    Market size and forecast

4.4.2.5.1.1.1.5.Other Neurostimulators

4.4.2.5.1.1.1.5.1.    Market size and forecast

4.4.2.5.1.2.    External Neurostimulators (Transcutaneous Electrical Nerve Stimulation (TENS))

4.4.2.5.1.2.1. Market size and forecast

4.4.3.    Market size and forecast, by region
4.4.4.    Market analysis by country

CHAPTER 5:    VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER

5.1.    Overview
5.2.    Market size and forecast
5.3.    Hospitals

5.3.1.    Market size and forecast, by region
5.3.2.    Market analysis by country

5.4.    Ambulatory surgical centers (ASCs)

5.4.1.    Market size and forecast, by region
5.4.2.    Market analysis by country

5.5.    Others

5.5.1.    Market size and forecast, by region
5.5.2.    Market analysis by country

CHAPTER 6:    VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY REGION

6.1.    OVERVIEW

6.1.1.    Market size and forecast

6.2.    North America

6.2.1.    Key market trends and opportunities
6.2.2.    North America vital organs support systems and medical bionics market, by country

6.2.2.1.    U.S. vital organs support systems and medical bionics market, by product type
6.2.2.2.    U.S. vital organs support systems and medical bionics market, by end user
6.2.2.3.    Canada vital organs support systems and medical bionics market, by product type
6.2.2.4.    Canada vital organs support systems and medical bionics market, by end user
6.2.2.5.    Mexico vital organs support systems and medical bionics market, by product type
6.2.2.6.    Mexico vital organs support systems and medical bionics market, by end user

6.2.3.    North America vital organs support systems and medical bionics market, by product type
6.2.4.    North America vital organs support systems and medical bionics market, by end user

6.3.    Europe

6.3.1.    Key market trends and opportunities
6.3.2.    Europe vital organs support systems and medical bionics market, by country

6.3.2.1.    Germany vital organs support systems and medical bionics market, by product type
6.3.2.3.    Germany vital organs support systems and medical bionics market, by end user
6.3.2.4.    France vital organs support systems and medical bionics market, by product type
6.3.2.6.    France vital organs support systems and medical bionics market, by end user
6.3.2.7.    Spain vital organs support systems and medical bionics market, by product type
6.3.2.8.    Spain vital organs support systems and medical bionics market, by end user
6.3.2.9.    Italy vital organs support systems and medical bionics market, by product type
6.3.2.11.    Italy vital organs support systems and medical bionics market, by end user
6.3.2.12.    UK vital organs support systems and medical bionics market, by product type
6.3.2.13.    UK vital organs support systems and medical bionics market, by end user
6.3.2.14.    Rest of Europe vital organs support systems and medical bionics market, by product type
6.3.2.15.    Rest of Europe vital organs support systems and medical bionics market, by end user

6.3.3.    Europe vital organs support systems and medical bionics market, by product type
6.3.4.    Europe vital organs support systems and medical bionics market, by end user

6.4.    Asia-Pacific

6.4.1.    Key market trends and opportunities
6.4.2.    Asia-Pacific vital organs support systems and medical bionics market, by country

6.4.2.1.    Australia vital organs support systems and medical bionics market, by product type
6.4.2.2.    Australia vital organs support systems and medical bionics market, by end user
6.4.2.3.    Japan vital organs support systems and medical bionics market, by product type
6.4.2.4.    Japan vital organs support systems and medical bionics market, by end user
6.4.2.5.    India vital organs support systems and medical bionics market, by product type
6.4.2.6.    India vital organs support systems and medical bionics market, by end user
6.4.2.7.    China vital organs support systems and medical bionics market, by product type
6.4.2.8.    China vital organs support systems and medical bionics market, by end user
6.4.2.9.    South Korea vital organs support systems and medical bionics market, by product type
6.4.2.10.    South Korea vital organs support systems and medical bionics market, by end user
6.4.2.11.    Rest of Asia-Pacific vital organs support systems and medical bionics market, by product type
6.4.2.12.    Rest of Asia-Pacific vital organs support systems and medical bionics market, by end user

6.4.3.    Asia-Pacific vital organs support systems and medical bionics market, by product type
6.4.5.    Asia-Pacific vital organs support systems and medical bionics market, by end user

6.5.    LAMEA

6.5.1.    Key market trends and opportunities
6.5.2.    LAMEA vital organs support systems and medical bionics market, by country

6.5.2.1.    Brazil vital organs support systems and medical bionics market, by product type
6.5.2.2.    Brazil vital organs support systems and medical bionics market, by end user
6.5.2.3.    Saudi Arabia vital organs support systems and medical bionics market, by product type
6.5.2.4.    Saudi Arabia vital organs support systems and medical bionics market, by end user
6.5.2.5.    South Africa vital organs support systems and medical bionics market, by product type
6.5.2.6.    South Africa vital organs support systems and medical bionics market, by end user
6.5.2.7.    Rest of LAMEA vital organs support systems and medical bionics market, by product type
6.5.2.8.    Rest of LAMEA vital organs support systems and medical bionics market, by end user

6.5.3.    LAMEA vital organs support systems and medical bionics market, by product type
6.5.4.    LAMEA vital organs support systems and medical bionics market, by end user

CHAPTER 7:    COMPETITIVE LANDSCAPE

7.1.    Introduction
7.2.    Top Player Positioning, 2018
7.3.    Top winning strategies

7.3.1.    Top Winning Strategies, By Year, 2015-2019*
7.3.2.    Top Winning Strategies, By Development, 2015-2019* (%)
7.3.3.    Top Winning Strategies, By Company, 2015-2019*

7.4.    Product Mapping of Top 12 Player

CHAPTER 8:    COMPANY PROFILES:

8.1.    Abiomed, Inc.

8.1.1.    Company overview
8.1.2.    Company snapshot
8.1.3.    Product portfolio
8.1.4.    Business performance
8.1.5.    Key strategic moves and developments

8.2.    Abbott Laboratories (St. Jude Medical)

8.2.1.    Company overview
8.2.2.    Company snapshot
8.2.3.    Operating business segments
8.2.4.    Product portfolio
8.2.5.    Business performance
8.2.6.    Key strategic moves and developments

8.3.    Asahi Kasei Corporation (Evaheart Medical U.S.A., Inc.)

8.3.1.    Company overview
8.3.2.    Company snapshot
8.3.3.    Operating business segments
8.3.4.    Product portfolio
8.3.5.    Business performance

8.4.    Baxter International Inc.

8.4.1.    Company overview
8.4.2.    Company snapshot
8.4.3.    Operating business segments
8.4.4.    Product portfolio
8.4.5.    Business performance
8.4.6.    Key strategic moves and developments

8.5.    Boston Scientific Corporation

8.5.1.    Company overview
8.5.2.    Company snapshot
8.5.3.    Operating business segments
8.5.4.    Product portfolio
8.5.5.    Business performance
8.5.6.    Key strategic moves and developments

8.6.    Cochlear Ltd.

8.6.1.    Company overview
8.6.2.    Company snapshot
8.6.3.    Operating business segments
8.6.4.    Product portfolio
8.6.5.    Business performance
8.6.6.    Key strategic moves and developments

8.7.    Edwards Lifesciences Corporation

8.7.1.    Company overview
8.7.2.    Company snapshot
8.7.3.    Operating business segments
8.7.4.    Product portfolio
8.7.5.    Business performance
8.7.6.    Key strategic moves and developments

8.8.    Jarvik Heart, Inc.

8.8.1.    Company overview
8.8.2.    Company snapshot
8.8.3.    Product portfolio
8.8.4.    Key strategic moves and developments

8.9.    Medtronic Plc. (Covidien Ltd.)

8.9.1.    Company overview
8.9.2.    Company snapshot
8.9.3.    Operating business segments
8.9.4.    Product portfolio
8.9.5.    Business performance
8.9.6.    Key strategic moves and developments

8.10.    Össur Americas, Inc.

8.10.1.    Company overview
8.10.2.    Company snapshot
8.10.3.    Operating business segments
8.10.4.    Product portfolio
8.10.5.    Business performance
8.10.6.    Key strategic moves and developments

8.11.    Second Sight Medical Products, Inc.

8.11.1.    Company overview
8.11.2.    Company snapshot
8.11.3.    Product portfolio
8.11.4.    Key strategic moves and developments

8.12.    SynCardia Systems LLC

8.12.1.    Company overview
8.12.2.    Company snapshot
8.12.3.    Product portfolio

LIST OF TABLES

TABLE 01.    GLOBAL VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)
TABLE 02.    VITAL ORGANS SUPPORT SYSTEMS MARKET REVENUE, BY TYPE, 2017–2025 ($MILLION)
TABLE 03.    VITAL ORGANS SUPPORT SYSTEMS MARKET REVENUE, BY REGION 2017–2025 ($MILLION)
TABLE 04.    MEDICAL BIONICS MARKET REVENUE, BY TYPE, 2017–2025 ($MILLION)
TABLE 05.    EAR BIONICS MARKET REVENUE, BY TYPE, 2017–2025 ($MILLION)
TABLE 06.    ORTHOPEDIC BIONICS MARKET REVENUE, BY TYPE, 2017–2025 ($MILLION)
TABLE 07.    LOWER LIMB MARKET REVENUE, BY TYPE, 2017–2025 ($MILLION)
TABLE 08.    ELECTRICAL BONE GROWTH STIMULATORS MARKET REVENUE, BY TYPE, 2017–2025 ($MILLION)
TABLE 09.    CARDIAC BIONICS MARKET REVENUE, BY TYPE, 2017–2025 ($MILLION)
TABLE 10.    PACEMAKER MARKET REVENUE, BY TYPE, 2017–2025 ($MILLION)
TABLE 11.    VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY TYPE, 2017–2025 ($MILLION)
TABLE 12.    ARTIFICIAL HEART VALVES MARKET REVENUE, BY TYPE, 2017–2025 ($MILLION)
TABLE 13.    NEURAL BIONICS MARKET REVENUE, BY TYPE, 2017–2025 ($MILLION)
TABLE 14.    INTERNAL NEUROSTIMULATORS MARKET REVENUE, BY TYPE, 2017–2025 ($MILLION)
TABLE 15.    MEDICAL BIONICS MARKET REVENUE, BY REGION 2017–2025 ($MILLION)
TABLE 16.    GLOBAL VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET REVENUE, BY END USER, 2017–2025 ($MILLION)
TABLE 17.    VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET REVENUE FOR HOSPITALS, BY REGION 2017–2025($MILLION)
TABLE 18.    VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET REVENUE FOR AMBULATORY SURGICAL CENTERS (ASC), BY REGION, 2017–2025($MILLION)
TABLE 19.    VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET REVENUE FOR OTHER END USERS, BY REGION, 2017–2025($MILLION)
TABLE 20.    VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET REVENUE, BY REGION, 2017–2025 ($MILLION)
TABLE 21.    NORTH AMERICA VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY COUNTRY, 2017–2025 ($MILLION)
TABLE 22.    U.S. VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 23.    U.S. VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 24.    CANADA VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 25.    CANADA VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 26.    MEXICO VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 27.    MEXICO VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 28.    NORTH AMERICA VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 29.    NORTH AMERICA VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 30.    EUROPE VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY COUNTRY, 2017–2025 ($MILLION)
TABLE 31.    GERMANY VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 32.    GERMANY VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 33.    FRANCE VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 34.    FRANCE VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 35.    SPAIN VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 36.    SPAIN VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 37.    ITALY VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 38.    ITALY VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 39.    UK VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 40.    UK VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 41.    REST OF EUROPE VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 42.    REST OF EUROPE VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 43.    EUROPE VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 44.    EUROPE VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 45.    ASIA-PACIFIC VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY COUNTRY, 2017–2025 ($MILLION)
TABLE 46.    AUSTRALIA VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 47.    AUSTRALIA VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 48.    JAPAN VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 49.    JAPAN VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 50.    INDIA VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 51.    INDIA VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 52.    CHINA VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 53.    CHINA VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 54.    SOUTH KOREA VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 55.    SOUTH KOREA VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 56.    REST OF ASIA-PACIFIC VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 57.    REST OF ASIA-PACIFIC VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 58.    ASIA-PACIFIC VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 59.    ASIA-PACIFIC VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 60.    LAMEA VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY COUNTRY, 2017–2025 ($MILLION)
TABLE 61.    BRAZIL VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 62.    BRAZIL VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 63.    SAUDI ARABIA VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 64.    SAUDI ARABIA VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 65.    SOUTH AFRICA VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 66.    SOUTH AFRICA VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 67.    REST OF LAMEA VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 68.    REST OF LAMEA VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 69.    LAMEA VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 70.    LAMEA VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 71.    ABIOMED: COMPANY SNAPSHOT
TABLE 72.    ABIOMED: PRODUCT PORTFOLIO
TABLE 73.    ABBOTT: COMPANY SNAPSHOT
TABLE 74.    ABBOTT: OPERATING SEGMENTS
TABLE 75.    ABBOTT: PRODUCT PORTFOLIO
TABLE 76.    ASAHI KASEI: COMPANY SNAPSHOT
TABLE 77.    ASAHI KASEI: OPERATING SEGMENTS
TABLE 78.    ASAHI KASEI: PRODUCT PORTFOLIO
TABLE 79.    BAXTER: COMPANY SNAPSHOT
TABLE 80.    BAXTER: OPERATING SEGMENTS
TABLE 81.    BAXTER: PRODUCT PORTFOLIO
TABLE 82.    BOSTON SCIENTIFIC: COMPANY SNAPSHOT
TABLE 83.    BOSTON SCIENTIFIC: OPERATING SEGMENTS
TABLE 84.    BOSTON SCIENTIFIC: PRODUCT PORTFOLIO
TABLE 85.    COCHLEAR: COMPANY SNAPSHOT
TABLE 86.    COCHLEAR: OPERATING SEGMENTS
TABLE 87.    COCHLEAR: PRODUCT PORTFOLIO
TABLE 88.    EDWARDS LIFESCIENCES: COMPANY SNAPSHOT
TABLE 89.    EDWARDS LIFESCIENCES: PRODUCT PORTFOLIO
TABLE 90.    JARVIK HEART: COMPANY SNAPSHOT
TABLE 91.    JARVIK HEART: PRODUCT PORTFOLIO
TABLE 92.    MEDTRONIC: COMPANY SNAPSHOT
TABLE 93.    MEDTRONIC: OPERATING SEGMENTS
TABLE 94.    MEDTRONIC: PRODUCT PORTFOLIO
TABLE 95.    ÖSSUR: COMPANY SNAPSHOT
TABLE 96.    ÖSSUR: OPERATING SEGMENTS
TABLE 97.    ÖSSUR: PRODUCT PORTFOLIO
TABLE 98.    SECOND SIGHT: COMPANY SNAPSHOT
TABLE 99.    SECOND SIGHT: PRODUCT PORTFOLIO
TABLE 100.    SYNCARDIA: COMPANY SNAPSHOT
TABLE 101.    SYNCARDIA: PRODUCT PORTFOLIO

LIST OF FIGURES

FIGURE 01.    KEY MARKET SEGMENTS
FIGURE 02.    EXECUTIVE SUMMARY
FIGURE 03.    TOP IMPACTING FACTORS
FIGURE 04.    TOP INVESTMENT POCKETS
FIGURE 05.    VALUE CHAIN ANALYSIS
FIGURE 06.    CLINICAL TRIALS IN MEDICAL BIONICS MARKET, BY REGION
FIGURE 07.    CLINICAL TRIALS FOR MEDICAL DEVICES (%)
FIGURE 08.    DISTRIBUTION OF DISABLING HEARING LOSS PATIENTS (%), 2018
FIGURE 09.    ARTIFICIAL HEART MARKET, 2017–2025 ($MILLION)
FIGURE 10.    ARTIFICIAL KIDNEY MARKET, 2017–2025 ($MILLION)
FIGURE 11.    ARTIFICIAL PANCREAS MARKET, 2017–2025 ($MILLION)
FIGURE 12.    ARTIFICIAL URINARY BLADDER MARKET, 2017–2025 ($MILLION)
FIGURE 13.    ARTIFICIAL LUNGS MARKET, 2017–2025 ($MILLION)
FIGURE 14.    ARTIFICIAL LIVER MARKET, 2017–2025 ($MILLION)
FIGURE 15.    COMPARATIVE SHARE ANALYSIS OF VITAL ORGANS SUPPORT SYSTEMS MARKET, BY COUNTRY, 2017 & 2025 (%)
FIGURE 16.    BIONIC EYE MARKET, 2017–2025 ($MILLION)
FIGURE 17.    COCHLEAR IMPLANTS MARKET, 2017–2025 ($MILLION)
FIGURE 18.    BONE ANCHORED HEARING SYSTEMS MARKET, 2017–2025 ($MILLION)
FIGURE 19.    AUDITORY BRAINSTEM IMPLANTS MARKET, 2017–2025 ($MILLION)
FIGURE 20.    UPPER LIMB MARKET, 2017–2025 ($MILLION)
FIGURE 21.    BIONIC KNEE MARKET, 2017–2025 ($MILLION)
FIGURE 22.    BIONIC FEET MARKET, 2017–2025 ($MILLION)
FIGURE 23.    EXOSKELETON MARKET, 2017–2025 ($MILLION)
FIGURE 24.    INVASIVE BONE GROWTH STIMULATORS MARKET, 2017–2025 ($MILLION)
FIGURE 25.    NON-INVASIVE BONE GROWTH STIMULATORS MARKET, 2017–2025 ($MILLION)
FIGURE 26.    IMPLANTABLE PACEMAKER MARKET, 2017–2025 ($MILLION)
FIGURE 27.    EXTERNAL PACEMAKER MARKET, 2017–2025 ($MILLION)
FIGURE 28.    LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, 2017–2025 ($MILLION)
FIGURE 29.    RIGHT VENTRICULAR ASSIST DEVICE (RVAD) MARKET, 2017–2025 ($MILLION)
FIGURE 30.    BIVENTRICULAR ASSIST DEVICE (BIVAD) MARKET, 2017–2025 ($MILLION)
FIGURE 31.    MECHANICAL HEART VALVES MARKET, 2017–2025 ($MILLION)
FIGURE 32.    TISSUE HEART VALVES MARKET, 2017–2025 ($MILLION)
FIGURE 33.    DEEP BRAIN STIMULATORS (DBS) MARKET, 2017–2025 ($MILLION)
FIGURE 34.    SACRAL NERVE STIMULATORS (SNS) MARKET, 2017–2025 ($MILLION)
FIGURE 35.    VAGUS NERVE STIMULATORS (VNS) MARKET, 2017–2025 ($MILLION)
FIGURE 36.    SPINAL CORD STIMULATORS (SCS) MARKET, 2017–2025 ($MILLION)
FIGURE 37.    MARKET FOR OTHER NEUROSTIMULATORS, 2017–2025 ($MILLION)
FIGURE 38.    EXTERNAL NEUROMODULATORS MARKET, 2017–2025 ($MILLION)
FIGURE 39.    COMPARATIVE SHARE ANALYSIS OF MEDICAL BIONICS MARKET, BY COUNTRY, 2017 & 2025 (%)
FIGURE 40.    COMPARATIVE SHARE ANALYSIS OF VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET FOR HOSPITALS, BY COUNTRY, 2017 & 2025 (%)
FIGURE 41.    COMPARATIVE SHARE ANALYSIS OF VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET FOR AMBULATORY SURGICAL CENTERS (ASC), BY COUNTRY, 2017 & 2025 (%)
FIGURE 42.    COMPARATIVE SHARE ANALYSIS OF VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET FOR OTHER END USERS, BY COUNTRY, 2017 & 2025 (%)
FIGURE 43.    GLOBAL VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS TOP PLAYER POSITIONING, 2017
FIGURE 44.    PRODUCT MAPPING OF TOP 12 PLAYERS
FIGURE 45.    ABIOMED: NET SALES, 2015–2017 ($MILLION)
FIGURE 46.    ABBOTT: NET SALES, 2016–2018 ($MILLION)
FIGURE 47.    ABBOTT: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 48.    ABBOTT: REVENUE SHARE BY REVENUE, 2017 (%)
FIGURE 49.    ASAHI KASEI: NET SALES, 2015–2017 ($MILLION)
FIGURE 50.    ASAHI KASEI: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 51.    ASAHI KASEI: REVENUE SHARE BY REVENUE, 2017 (%)
FIGURE 52.    BAXTER: NET SALES, 2015–2017 ($MILLION)
FIGURE 53.    BAXTER: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 54.    BAXTER: REVENUE SHARE BY REVENUE, 2017 (%)
FIGURE 55.    BOSTON SCIENTIFIC: NET SALES, 2016–2018 ($MILLION)
FIGURE 56.    BOSTON SCIENTIFIC: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 57.    BOSTON SCIENTIFIC: REVENUE SHARE BY REVENUE, 2018 (%)
FIGURE 58.    COCHLEAR: NET SALES, 2016–2018 ($MILLION)
FIGURE 59.    COCHLEAR: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 60.    COCHLEAR: REVENUE SHARE BY REVENUE, 2018 (%)
FIGURE 61.    EDWARDS LIFESCIENCES: NET SALES, 2015–2017 ($MILLION)
FIGURE 62.    EDWARDS LIFESCIENCES: REVENUE SHARE BY PRODUCT, 2017 (%)
FIGURE 63.    EDWARDS LIFESCIENCES: REVENUE SHARE BY REVENUE, 2017 (%)
FIGURE 64.    MEDTRONIC: NET SALES, 2016–2018 ($MILLION)
FIGURE 65.    MEDTRONIC: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 66.    MEDTRONIC: REVENUE SHARE BY REVENUE, 2018 (%)
FIGURE 67.    ÖSSUR: NET SALES, 2016–2018 ($MILLION)
FIGURE 68.    ÖSSUR: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 69.    ÖSSUR: REVENUE SHARE BY REVENUE, 2018 (%)

 
 

The field of vital organs support systems and medical bionics has witnessed several technological advancements in the recent years. For instance, the cochlear implants available in the present scenario have speech recognition in difficult listening situations, which help to differentiate speech in noisy & reverberant situation, understand sound from television or telephone, and identify a sound from distance. Chinese scientists have developed an artificial heart using rocket technology (using magnetic and fluid levitation from a rocket system). This new total artificial heart is currently undergoing testing and clinical trials.

The adoption of vital organs support systems and medical bionics is expected to increase in the near future, due to the demand–supply gap. The demand of the organ transplantation is high; however, supply is less, owing to the scarcity of donor organs. In addition, technological advancements in the artificial organ sector and increased R&D expenditure further drive the market growth.

Based on product, the market is segmented into vital organs support systems and medical bionics. The vital organs support systems segment is further segmented into artificial heart, artificial kidney, artificial pancreas, artificial urinary bladder, artificial lungs, and artificial liver. The medical bionics segment is subsegmented into bionic eye, ear bionics, orthopedic bionics, cardiac bionics, and neural bionics. The medical bionics segment was the major revenue contributor in 2017, and is anticipated to continue this trend during the forecast period, owing to rise in geriatric population, upsurge in number of patients suffering from chronic diseases, and increase in government focus on funding R&D initiatives.

North America was the leading revenue contributor to the global vital organs support systems and medical bionics market in 2017, and is expected to remain dominant throughout the forecast period due to the growth in the incidence of chronic diseases such as cardiac and neural diseases along with rise in elderly population and high adoption of technologically advanced devices such as total artificial heart boosts the market growth.
 

 

PURCHASE OPTIONS

Start reading instantly ,This title and over 12000 thousand more,available with Avenue Library, Subcription @ $649 T&C*

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,   
Int'l : +1-503-894-6022
( Europe )
+ 44-845-528-1300
Drop us an email at
help@alliedmarketresearch.com

Send Enquiry

Download Sample

Request Customization

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 

FREQUENTLY ASKED
QUESTIONS?

 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 

Download Sample

OR

Purchase Full Report of
Vital Organs Support Systems and Medical Bionics Market

  • Online Only
  • $3,456  $3,041
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $3,840  $3,379
  • Restricted to one authorized user
  • One print only
  • Available in Excel
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $5,370  $4,296
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,450  $4,838
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise
    License/PDF

  • $8,995  $6,297
  • Unlimited within company/enterprise
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Library Access
  • $0.00
  • Published Content E-Access
  • Company Profiles E-Access
  • Newly Added Content Access
  • 10 PDF Downloads
  • 5 Excel Data Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Start reading instantly
    ,This title and over 12000 thousand more,available with Avenue Library, Subcription @ $649 T&C*

    Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 

Featured Readings

 

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 
Download Sample